How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.

Abstract excerpt

Myelodysplastic syndromes (MDS) can be difficult to diagnose, especially when morphological changes in blood and marrow cells are minimal, myeloblast proportion is not increased, and the karyotype is normal. The discovery of >40 genes that are recurrently somatically mutated in MDS patients raised hope that molecular genetic testing for these mutations might help clarify the diagnosis in ambiguous cases where...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Progression
• Share to Genetic Testing
• Share to Genomics